Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
Clinical trial NCT00915018 · COMPLETED
Trial details
- NCT number
- NCT00915018
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-21
- Primary completion
- 2013-08-01
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.